| 5301 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
26 |
| 5302 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
52 |
| 5303 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
38 |
| 5304 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
56 |
| 5305 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia – Relapse
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
51 |
| 5306 |
Apheresis |
Autologous
|
Amyloidosis
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
60 |
| 5307 |
Apheresis |
Allogeneic
|
Aplasia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
51 |
| 5308 |
Apheresis |
Allogeneic
|
Aplastic Anemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
16 |
| 5309 |
Apheresis |
Allogeneic
|
B-Cell Acute Lymphoblastic Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
8 |
| 5310 |
Apheresis |
Allogeneic
|
B-Cell Acute Lymphoblastic Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
46 |
| 5311 |
Apheresis |
Allogeneic
|
B-Cell Acute Lymphoblastic Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
21 |
| 5312 |
Apheresis |
Allogeneic
|
B-Cell Acute Lymphoblastic Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
28 |
| 5313 |
Apheresis |
Allogeneic
|
B-Cell Chronic Lymphoblastic Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
66 |
| 5314 |
Apheresis |
Autologous
|
B-Cell Non-Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
66 |
| 5315 |
Apheresis |
Allogeneic
|
Chronic Granulomatous Disease
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
2 |
| 5316 |
Apheresis |
Allogeneic
|
Chronic Granulomatous Disease
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
16 |
| 5317 |
Apheresis |
Allogeneic
|
Chronic Granulomatous Disease
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
3 |
| 5318 |
Apheresis |
Allogeneic
|
Chronic Lymphocytic Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
58 |
| 5319 |
Apheresis |
Allogeneic
|
Chronic Lymphocytic Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
65 |
| 5320 |
Apheresis |
Allogeneic
|
Chronic Lymphocytic Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
69 |
| 5321 |
Apheresis |
Allogeneic
|
Chronic Lymphocytic Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
65 |
| 5322 |
Apheresis |
Allogeneic
|
Chronic Lymphocytic Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
60 |
| 5323 |
Apheresis |
Allogeneic
|
Chronic Lymphocytic Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
69 |
| 5324 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
23 |
| 5325 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
34 |
| 5326 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
37 |
| 5327 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
56 |
| 5328 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
58 |
| 5329 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
56 |
| 5330 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
31 |
| 5331 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
54 |
| 5332 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
46 |
| 5333 |
Apheresis |
Allogeneic
|
Chronic Myelomonocytic Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
54 |
| 5334 |
Apheresis |
Allogeneic
|
Chronic Myelomonocytic Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
65 |
| 5335 |
Apheresis |
Allogeneic
|
Chronic Myelomonocytic Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
73 |
| 5336 |
Apheresis |
Allogeneic
|
Chronic Myelomonocytic Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
62 |
| 5337 |
Apheresis |
Autologous
|
Diffuse Large B-Cell Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
66 |
| 5338 |
Apheresis |
Autologous
|
Embryonal Cell Carcinoma Of The Testicle
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
29 |
| 5339 |
Apheresis |
Allogeneic
|
Extracranial Malignant Germ Cell Tumors
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
53 |
| 5340 |
Apheresis |
Allogeneic
|
Glanzmann Thrombasthenia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
11 |
| 5341 |
Apheresis |
Allogeneic
|
High-Risk Myelodysplastic Syndrome
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
61 |
| 5342 |
Apheresis |
Allogeneic
|
Histiocytosis X
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
14 |
| 5343 |
Apheresis |
Allogeneic
|
Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
65 |
| 5344 |
Apheresis |
Allogeneic
|
Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
58 |
| 5345 |
Apheresis |
Allogeneic
|
Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
28 |
| 5346 |
Apheresis |
Allogeneic
|
Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
44 |
| 5347 |
Apheresis |
Allogeneic
|
Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
1 |
| 5348 |
Apheresis |
Allogeneic
|
Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
32 |
| 5349 |
Apheresis |
Allogeneic
|
Hodgkin Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
34 |
| 5350 |
Apheresis |
Allogeneic
|
Mantle Cell Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
62 |
| 5351 |
Apheresis |
Allogeneic
|
Mantle Cell Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
69 |
| 5352 |
Apheresis |
Allogeneic
|
Mantle Cell Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
65 |
| 5353 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
66 |
| 5354 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
63 |
| 5355 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
59 |
| 5356 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
68 |
| 5357 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
65 |
| 5358 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
54 |
| 5359 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
64 |
| 5360 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
59 |
| 5361 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
59 |
| 5362 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
71 |
| 5363 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
63 |
| 5364 |
Apheresis |
Allogeneic
|
Mixed Phenotype Acute Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
59 |
| 5365 |
Apheresis |
Allogeneic
|
Mixed Phenotype Acute Leukemia
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
49 |
| 5366 |
Apheresis |
Autologous
|
Monoclonal Gammopathy Of Undetermined Significance-Sporadic Late Onset Nemaline Myopathy
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
36 |
| 5367 |
Apheresis |
Autologous
|
Morbus Hodgkin
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
66 |
| 5368 |
Apheresis |
Allogeneic
|
Mucopolysaccharidosis Type I
|
Metabolic
|
2019
|
Standard Therapy
|
Poland
|
1 |
| 5369 |
Apheresis |
Allogeneic
|
Mucopolysaccharidosis Type Ii
|
Metabolic
|
2019
|
Standard Therapy
|
Poland
|
2 |
| 5370 |
Apheresis |
Allogeneic
|
Mucopolysaccharidosis Type Ii
|
Metabolic
|
2019
|
Standard Therapy
|
Poland
|
2 |
| 5371 |
Apheresis |
Allogeneic
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
52 |
| 5372 |
Apheresis |
Allogeneic
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Poland
|
55 |
| 5373 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
68 |
| 5374 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
58 |
| 5375 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
58 |
| 5376 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
69 |
| 5377 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
58 |
| 5378 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
65 |
| 5379 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
52 |
| 5380 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
56 |
| 5381 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
54 |
| 5382 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
51 |
| 5383 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
57 |
| 5384 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
52 |
| 5385 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
61 |
| 5386 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
68 |
| 5387 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
59 |
| 5388 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
64 |
| 5389 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
39 |
| 5390 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
52 |
| 5391 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
59 |
| 5392 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
63 |
| 5393 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
40 |
| 5394 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
57 |
| 5395 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
53 |
| 5396 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
64 |
| 5397 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
70 |
| 5398 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
68 |
| 5399 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
56 |
| 5400 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2019
|
Standard Therapy
|
Germany
|
63 |